Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | PRKCA | P17252 | 2/20 | 0.41 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.41 |
| ▸ | CTSK | P43235 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 5/20 | 0.35 |
| ▸ | CA1 | P00915 | 3/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.34 |
| ▸ | CTSL | P07711 | 1/20 | 0.33 |
| ▸ | CTSB | P07858 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL819755 | 0.95 | TSHR (0.46) | TSHRALDH1A1PRKCAPRKCDCTSK | |
| SCHEMBL3183024 | 0.90 | TSHR (0.47) | TSHRALDH1A1PRKCAPRKCDCTSK | |
| SCHEMBL15519639 | 0.90 | ALDH1A1 (0.50) | TSHRALDH1A1PRKCAPRKCDCTSK | |
| SCHEMBL16174643 | 0.89 | TSHR (0.46) | TSHRALDH1A1MAPK1LMNACA2 | |
| SCHEMBL5889388 | 0.86 | ALDH1A1 (0.57) | TSHRALDH1A1CTSKCTSLCTSB | |
| SCHEMBL15519449 | 0.83 | ALDH1A1 (0.53) | TSHRALDH1A1PRKCAPRKCDCTSK | |
| SCHEMBL1990973 | 0.83 | ALDH1A1 (0.51) | TSHRALDH1A1MAPK1LMNACA2 | |
| SCHEMBL1902715 | 0.82 | ALDH1A1 (0.49) | TSHRALDH1A1CTSKMAPK1LMNA | |
| SCHEMBL26675834 | 0.82 | TSHR (0.42) | TSHRALDH1A1MAPK1LMNA | |
| SCHEMBL28119981 | 0.81 | TSHR (0.47) | TSHRALDH1A1CTSKMAPK1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026104704-A1 | A COMBINATION, MEDICAL KIT AND MEDICAL DEVICE FOR TREATING AND/OR PREVENTING TISSUE LEAKAGE | FUNDACIÓ INSTITUT DE INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL (ES) | 2026-05-21 | — | — | WO | claimed |
| EP-4744687-A1 | A COMBINATION, MEDICAL KIT AND MEDICAL DEVICE FOR TREATING AND/OR PREVENTING TISSUE LEAKAGE | Aesculap AG (DE) | 2026-05-20 | — | — | EP | claimed |
| WO-2026104704-A1 | A COMBINATION, MEDICAL KIT AND MEDICAL DEVICE FOR TREATING AND/OR PREVENTING TISSUE LEAKAGE | FUNDACIÓ INSTITUT DE INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL (ES) | 2026-05-21 | — | — | WO | disclosed |
| EP-4744687-A1 | A COMBINATION, MEDICAL KIT AND MEDICAL DEVICE FOR TREATING AND/OR PREVENTING TISSUE LEAKAGE | Aesculap AG (DE) | 2026-05-20 | — | — | EP | disclosed |
| US-20250339579-A1 | SURGICAL THREAD, SURGICAL SUTURE AND SURGICAL KIT | B BRAUN SURGICAL SA (ES) | 2025-11-06 | — | — | US | disclosed |
| EP-4531939-A1 | SURGICAL THREAD, SURGICAL SUTURE AND SURGICAL KIT | B. Braun Surgical, S.A. (ES) | 2025-04-09 | — | — | EP | disclosed |
| WO-2023233011-A1 | SURGICAL THREAD, SURGICAL SUTURE AND SURGICAL KIT | B. BRAUN SURGICAL S.A. (ES) | 2023-12-07 | — | — | WO | disclosed |
| EP-4285946-A1 | SURGICAL THREAD, SURGICAL SUTURE AND SURGICAL KIT | B. Braun Surgical, S. A. (ES) | 2023-12-06 | — | — | EP | disclosed |
| US-20220160645-A1 | NANOPARTICLES COMPRISING COPOLYMERIC OR HOMOPOLYMERIC COMPOUNDS WHICH COMPRISE CYANOACRYLATE SUBUNITS | SINTEF TTO AS (NO) | 2022-05-26 | — | — | US | disclosed |
| EP-2708245-B1 | COMPOSITION, REACTION PRODUCT, KIT AND APPLICATOR, ESPECIALLY FOR USE IN MEDICINE | AESCULAP AG (DE) | 2019-03-20 | — | — | EP | disclosed |
| EP-2708245-A2 | Composition, reaction product, kit and applicator, especially for use in medicine | AESCULAP AG (DE) | 2014-03-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220160645-A1 | NANOPARTICLES COMPRISING COPOLYMERIC OR HOMOPOLYMERIC COMPOUNDS WHICH COMPRISE CYANOACRYLATE SUBUNITS | CD47, PSMA2, C3AR1 | TSHR 4838/4885ALDH1A1 1403/4885PRKCA 3421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.